AI Verdict
BSX has stronger fundamentals based on our AI analysis.
BSX vs ELV Fundamental Comparison
| Metric | BSX | ELV |
|---|---|---|
| Revenue | $20.1B | $199.1B |
| Net Income | $2.9B | $5.7B |
| Net Margin | 14.4% | 2.8% |
| ROE | 12.0% | 12.9% |
| ROA | 6.6% | 4.7% |
| Current Ratio | 1.62x | 1.54x |
| Debt/Equity | 0.46x | 0.73x |
| EPS | $1.94 | $25.21 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs ELV: Frequently Asked Questions
Is BSX or ELV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), BSX has stronger fundamentals. BSX is rated BUY (80% confidence) while ELV is rated BUY (75% confidence). This is not investment advice.
How does BSX compare to ELV fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 12.0% vs Elevance Health, Inc.'s 12.9%. Net margins are 14.4% vs 2.8% respectively.
Which stock pays higher dividends, BSX or ELV?
BSX has a dividend yield of N/A or no dividend while ELV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or ELV for long term?
For long-term investing, consider that BSX has BUY rating with 80% confidence, while ELV has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs ELV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs ELV, the AI consensus favors BSX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.